U.S. flag

An official website of the United States government

NM_145239.3(PRRT2):c.433dup (p.Arg145fs) AND not provided

Germline classification:
Pathogenic (2 submissions)
Last evaluated:
Oct 1, 2021
Review status:
2 stars out of maximum of 4 stars
criteria provided, multiple submitters, no conflicts
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV000188785.23

Allele description [Variation Report for NM_145239.3(PRRT2):c.433dup (p.Arg145fs)]

NM_145239.3(PRRT2):c.433dup (p.Arg145fs)

Genes:
MVP-DT:MVP divergent transcript [Gene - HGNC]
PRRT2:proline rich transmembrane protein 2 [Gene - OMIM - HGNC]
Variant type:
Duplication
Cytogenetic location:
16p11.2
Genomic location:
Preferred name:
NM_145239.3(PRRT2):c.433dup (p.Arg145fs)
HGVS:
  • NC_000016.10:g.29813487dup
  • NG_032039.1:g.6400dup
  • NM_001256442.2:c.433dup
  • NM_001256443.2:c.433dup
  • NM_145239.3:c.433dupMANE SELECT
  • NP_001243371.1:p.Arg145fs
  • NP_001243372.1:p.Arg145fs
  • NP_660282.2:p.Arg145fs
  • NC_000016.9:g.29824808dup
  • NM_145239.2:c.433dupC
  • p.R145PfsX25
Protein change:
R145fs
Links:
dbSNP: rs796052944
NCBI 1000 Genomes Browser:
rs796052944
Molecular consequence:
  • NM_001256442.2:c.433dup - frameshift variant - [Sequence Ontology: SO:0001589]
  • NM_001256443.2:c.433dup - frameshift variant - [Sequence Ontology: SO:0001589]
  • NM_145239.3:c.433dup - frameshift variant - [Sequence Ontology: SO:0001589]
Observations:
2

Condition(s)

Synonyms:
none provided
Identifiers:
MedGen: C3661900

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV000242409GeneDx
criteria provided, single submitter

(GeneDx Variant Classification (06012015))
Pathogenic
(Oct 8, 2014)
germlineclinical testing

Citation Link,

SCV001501610CeGaT Center for Human Genetics Tuebingen
criteria provided, single submitter

(CeGaT Center For Human Genetics Tuebingen Variant Classification Criteria Version 2)
Pathogenic
(Oct 1, 2021)
germlineclinical testing

Citation Link

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineyes2not providednot providednot providednot providedclinical testing

Details of each submission

From GeneDx, SCV000242409.3

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testingnot provided

Description

c.433dupC: p.Arg145ProfsX25 (R145PfsX25) in exon 2 of the PRRT2 gene (NM_145239.2). The normal sequence with the base that is duplicated in braces is: ACCCC{C}GGCC. The c.433dupC mutation in the PRRT2 gene causes a frameshift starting with codon Arginine 145, changes this amino acid to a Proline residue and creates a premature Stop codon at position 25 of the new reading frame, denoted p.Arg145ProfsX25. This mutation is predicted to cause loss of normal protein function either through protein truncation or nonsense-mediated mRNA decay. Although this mutation has not been previously reported to our knowledge, a deletion at the same position (c.433delC) has been reported in association with PRRT2-related disorders (Cloarec et al., 2012), and other frameshift mutations in this region of the PRRT2 gene have been reported in association with PRRT2-related disorders. The variant is found in INFANT-EPI panel(s).

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineyesnot providednot providednot providednot providednot providednot providednot provided

From CeGaT Center for Human Genetics Tuebingen, SCV001501610.23

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not provided2not providednot providedclinical testingnot provided
#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineyesnot providednot providednot provided2not providednot providednot provided

Last Updated: Oct 20, 2024